Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft-versus-Host Disease-Reference-Cited by-同舟云学术

Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft-versus-Host Disease

Published:2014-10 Issue:10 Volume:20 Page:1580-1585
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Sánchez-Guijo Fermín,Caballero-Velázquez Teresa,López-Villar Olga,Redondo Alba,Parody Rocío,Martínez Carmen,Olavarría Eduardo,Andreu Enrique,Prósper Felipe,Díez-Campelo María,Regidor Carmen,Villaron Eva,López-Corral Lucía,Caballero Dolores,Cañizo María-Consuelo del,Pérez-Simon José Antonio

Funder

Ministerio de Sanidad

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference36 articles.

1. Pathogenesis and management of graft-versus-host disease;Choi;Immunol Allergy Clin North Am,2010

2. Secondary treatment of acute graft-versus-host disease: a critical review;Martin;Biol Blood Marrow Transplant,2012

3. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement;Dominici;Cytotherapy,2006

4. Regulation of mesenchymal stem cell differentiation;Cook;Adv Exp Med Bio,2013

5. Immunomodulatory properties and therapeutic application of mesenchymal stem cells;Shi;Clin Exp Immunol,2011

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of post-allogeneic hematopoietic stem cell transplant cytopenias with sequential doses of multipotent mesenchymal stromal/stem cells;Cytotherapy;2024-08

2. Mesenchymal stromal cells in the treatment of pediatric hematopoietic cell transplantation-related complications (graft vs. host disease, hemorrhagic cystitis, graft failure and poor graft function): a single center experience;Frontiers in Pediatrics;2024-05-09

3. Cell-based Therapies for Acute Respiratory Distress Syndrome: Where Are We Now?;American Journal of Respiratory and Critical Care Medicine;2024-04-01

4. Mesenchymal stem cells preconditioned with a TLR5 agonist enhanced immunoregulatory effect through M2 macrophage polarization in a murine graft-versus-host disease model;International Journal of Medical Sciences;2024

5. Mesenchymal stem cell-derived exosomes can alleviate GVHD and preserve the GVL effect in allogeneic stem cell transplantation animal models;Frontiers in Immunology;2023-12-06